Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4- and IL-13-dependent signal transduction - PubMed (original) (raw)
. 1998 Dec 18;273(51):33893-6.
doi: 10.1074/jbc.273.51.33893.
Affiliations
- PMID: 9852037
- DOI: 10.1074/jbc.273.51.33893
Free article
Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4- and IL-13-dependent signal transduction
S J Haque et al. J Biol Chem. 1998.
Free article
Abstract
Binding of interleukin (IL)-4 to its transmembrane receptor results in the Jak-mediated tyrosine phosphorylation of a number of protein components of the IL-4 signaling cascade, including Jak1, Jak2, Jak3, Tyk2, IL-4Ralpha, IRS-1, IRS-2, and Stat6 in appropriate cell types. However, the protein-tyrosine phosphatases (PTPs) that dephosphorylate these proteins and terminate signaling remained unidentified. We have noted that IL-4-dependent activation of Stat6 is sustained longer in fibroblasts than in lymphoid cells. Because Shp-1, an SH2 domain-containing PTP, is expressed primarily in hematopoietic cells, we examined whether Shp-1 activity could regulate IL-4-dependent cell signaling. Expression of an Shp-1 transgene in NIH 3T3 cells markedly reduces both IL-4-dependent Stat6 activation and Stat6-mediated transcription of IL-4-responsive genes. In accord with this, IL-4 treatment of bone marrow-derived macrophages from viable motheaten mice that express substantially reduced levels of Shp-1 activity show remarkably enhanced activation of Stat6. In addition, Stat6 activation by IL-4 is significantly enhanced in pre-B cells derived from motheaten (Shp-1 null mutant) mice compared with normal pre-B cells derived from control animals. These data clearly implicate Shp-1 in the negative regulation of the IL-4/IL-13-activated Jak-Stat pathway.
Similar articles
- Immunoreceptor tyrosine-based inhibitory motif of the IL-4 receptor associates with SH2-containing phosphatases and regulates IL-4-induced proliferation.
Kashiwada M, Giallourakis CC, Pan PY, Rothman PB. Kashiwada M, et al. J Immunol. 2001 Dec 1;167(11):6382-7. doi: 10.4049/jimmunol.167.11.6382. J Immunol. 2001. PMID: 11714803 - Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1.
David M, Chen HE, Goelz S, Larner AC, Neel BG. David M, et al. Mol Cell Biol. 1995 Dec;15(12):7050-8. doi: 10.1128/MCB.15.12.7050. Mol Cell Biol. 1995. PMID: 8524272 Free PMC article. - IL-4/IL-13 signaling beyond JAK/STAT.
Jiang H, Harris MB, Rothman P. Jiang H, et al. J Allergy Clin Immunol. 2000 Jun;105(6 Pt 1):1063-70. doi: 10.1067/mai.2000.107604. J Allergy Clin Immunol. 2000. PMID: 10856136 Review. - Regulation of B cell signal transduction by SH2-containing protein-tyrosine phosphatases.
Siminovitch KA, Neel BG. Siminovitch KA, et al. Semin Immunol. 1998 Aug;10(4):329-47. doi: 10.1006/smim.1998.0125. Semin Immunol. 1998. PMID: 9695189 Review.
Cited by
- Phosphatase SHP1 impedes mesenchymal stromal cell immunosuppressive capacity modulated by JAK1/STAT3 and P38 signals.
Jiang M, Ye J, Wang X, Li N, Wang Y, Shi Y. Jiang M, et al. Cell Biosci. 2020 May 14;10:65. doi: 10.1186/s13578-020-00428-w. eCollection 2020. Cell Biosci. 2020. PMID: 32467752 Free PMC article. - Redox regulation of interleukin-4 signaling.
Sharma P, Chakraborty R, Wang L, Min B, Tremblay ML, Kawahara T, Lambeth JD, Haque SJ. Sharma P, et al. Immunity. 2008 Oct 17;29(4):551-64. doi: 10.1016/j.immuni.2008.07.019. Immunity. 2008. PMID: 18957266 Free PMC article. - Consideration of SHP-1 as a Molecular Target for Tumor Therapy.
Lim S, Lee KW, Kim JY, Kim KD. Lim S, et al. Int J Mol Sci. 2023 Dec 26;25(1):331. doi: 10.3390/ijms25010331. Int J Mol Sci. 2023. PMID: 38203502 Free PMC article. Review. - Novel SHP-1 inhibitors tyrosine phosphatase inhibitor-1 and analogs with preclinical anti-tumor activities as tolerated oral agents.
Kundu S, Fan K, Cao M, Lindner DJ, Zhao ZJ, Borden E, Yi T. Kundu S, et al. J Immunol. 2010 Jun 1;184(11):6529-36. doi: 10.4049/jimmunol.0903562. Epub 2010 Apr 26. J Immunol. 2010. PMID: 20421638 Free PMC article. - Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype.
Christophi GP, Panos M, Hudson CA, Christophi RL, Gruber RC, Mersich AT, Blystone SD, Jubelt B, Massa PT. Christophi GP, et al. Lab Invest. 2009 Jul;89(7):742-59. doi: 10.1038/labinvest.2009.32. Epub 2009 Apr 27. Lab Invest. 2009. PMID: 19398961 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous